Outcomes Associated With Invasive and Noninvasive Ventilation Among Patients Hospitalized With Exacerbations of Chronic Obstructive Pulmonary Disease

Authors:

Abstract
Chronic obstructive pulmonary disease (COPD) affects 4% to 7% of US adults, results in more than 800 000 hospitalizations annually, and is the nation’s third leading cause of death.1-3 Treatment for patients hospitalized with exacerbation include supplemental oxygen, short-acting bronchodilators, systemic corticosteroids, and, in most instances, antibiotics.4-6 Meta-analyses of randomized clinical trials suggest that when administered to carefully selected patients, noninvasive ventilation (NIV) can reduce the risk of death by up to 55%,5,7 the only hospital-based intervention known to improve mortality. This benefit is thought to be mediated through the prevention of complications associated with invasive mechanical ventilation (IMV), including ventilator-associated pneumonia and barotrauma.8-10

This publication has 31 references indexed in Scilit: